Grantham, Mayo, Van Otterloo & Co. LLC
- SEC CIK
- 0001352662
- Latest filing
- Aug 13, 2026
NVO holding history
Novo Nordisk A S in every 13F filed by Grantham, Mayo, Van Otterloo & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVO overviewAll 13F holders of NVOFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2025
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −27,971−100.0% | Sold out | Holders |
| Q1 2026 | 27,971 | $1.03M | <0.1% | −157,000−84.9% | Reduced | Holders |
| Q4 2025 | 184,971 | $9.41M | <0.1% | +108,359+141.4% | Added | Holders |
| Q3 2025 | 76,612 | $4.25M | <0.1% | +15,027+24.4% | Added | Holders |
| Q2 2025 | 61,585 | $4.25M | <0.1% | +23,968+63.7% | Added | Holders |
| Q1 2025 | 37,617 | $2.61M | <0.1% | +37,617 | New | Holders |